Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2024 Results
Legend Biotech (NASDAQ: LEGN), a global leader in cell therapy, has announced it will host an investor conference call on Tuesday, March 11, 2025, at 8:00 am ET to review its fourth quarter and full year 2024 financial results.
During the webcast and conference call, senior leadership will provide an overview of Legend Biotech's quarterly and fiscal year performance. Investors and interested parties can join the live audio webcast via a provided weblink.
A replay of the webcast and the earnings news release will be made available through the Investor Relations section of Legend Biotech's website under the Events and Presentation section approximately two hours after the call concludes.
Legend Biotech (NASDAQ: LEGN), un leader globale nella terapia cellulare, ha annunciato che ospiterà una conferenza telefonica per gli investitori il martedì 11 marzo 2025 alle 8:00 ET per rivedere i suoi risultati finanziari del quarto trimestre e dell'intero anno 2024.
Durante la trasmissione in diretta e la conferenza telefonica, i dirigenti senior forniranno una panoramica delle prestazioni trimestrali e annuali di Legend Biotech. Gli investitori e le parti interessate possono partecipare alla trasmissione audio in diretta tramite un link fornito.
Una registrazione della trasmissione e il comunicato stampa sugli utili saranno resi disponibili nella sezione Relazioni con gli Investitori del sito web di Legend Biotech, sotto la sezione Eventi e Presentazioni, circa due ore dopo la conclusione della chiamata.
Legend Biotech (NASDAQ: LEGN), un líder global en terapia celular, ha anunciado que llevará a cabo una conferencia telefónica para inversores el martes 11 de marzo de 2025 a las 8:00 am ET para revisar sus resultados financieros del cuarto trimestre y del año completo 2024.
Durante la transmisión web y la conferencia telefónica, los altos directivos proporcionarán una visión general del rendimiento trimestral y anual de Legend Biotech. Los inversores y partes interesadas pueden unirse a la transmisión de audio en vivo a través de un enlace proporcionado.
Una repetición de la transmisión y el comunicado de ganancias estarán disponibles en la sección de Relaciones con Inversores del sitio web de Legend Biotech, bajo la sección de Eventos y Presentaciones, aproximadamente dos horas después de que concluya la llamada.
레전드 바이오텍 (NASDAQ: LEGN), 세포 치료의 글로벌 리더, 가 2025년 3월 11일 화요일 오전 8시 ET에 투자자 컨퍼런스 콜을 개최하여 2024년 4분기 및 전체 연도 재무 결과를 검토할 것이라고 발표했습니다.
웹캐스트 및 컨퍼런스 콜 동안, 고위 경영진이 레전드 바이오텍의 분기 및 회계 연도 성과에 대한 개요를 제공할 것입니다. 투자자 및 관심 있는 당사자는 제공된 링크를 통해 실시간 오디오 웹캐스트에 참여할 수 있습니다.
웹캐스트의 재생 및 수익 뉴스 릴리스는 레전드 바이오텍 웹사이트의 투자자 관계 섹션의 이벤트 및 프레젠테이션 섹션에서 통화 종료 약 두 시간 후에 제공될 것입니다.
Legend Biotech (NASDAQ: LEGN), un leader mondial dans la thérapie cellulaire, a annoncé qu'il tiendra une conférence téléphonique pour les investisseurs le mardi 11 mars 2025 à 8h00 ET pour examiner ses résultats financiers du quatrième trimestre et de l'année complète 2024.
Au cours du webinaire et de la conférence téléphonique, la direction fournira un aperçu des performances trimestrielles et annuelles de Legend Biotech. Les investisseurs et les parties intéressées peuvent rejoindre le webinaire audio en direct via un lien fourni.
Un enregistrement du webinaire et le communiqué de presse sur les résultats seront disponibles dans la section Relations avec les investisseurs du site web de Legend Biotech, sous la rubrique Événements et Présentations, environ deux heures après la fin de l'appel.
Legend Biotech (NASDAQ: LEGN), ein globaler Marktführer in der Zelltherapie, hat angekündigt, am Dienstag, den 11. März 2025, um 8:00 Uhr ET eine Investorenkonferenzschaltung abzuhalten, um die Finanzergebnisse des vierten Quartals und des gesamten Jahres 2024 zu überprüfen.
Während des Webcasts und der Konferenzschaltung wird die Unternehmensführung einen Überblick über die vierteljährliche und jährliche Leistung von Legend Biotech geben. Investoren und interessierte Parteien können über einen bereitgestellten Link an der Live-Audio-Webcast teilnehmen.
Eine Wiederholung des Webcasts und die Pressemitteilung zu den Gewinnen werden etwa zwei Stunden nach Abschluss des Anrufs im Bereich Investor Relations der Legend Biotech-Website unter der Rubrik Veranstaltungen und Präsentationen verfügbar sein.
- None.
- None.
SOMERSET, N.J., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, will host a conference call for investors at 8:00 am ET on Tuesday, March 11, 2025, to review fourth-quarter and full-year 2024 results.
During the webcast and conference call, senior leaders will provide an overview of Legend Biotech’s quarter and fiscal year performance.
Investors and other interested parties may join the live audio webcast of the call via this weblink.
A replay version of the webcast and earnings news release will be available through the Investor Relations section of Legend Biotech’s website under the Events and Presentation section approximately two hours after the call concludes.
ABOUT LEGEND BIOTECH
With over 2,500 employees, Legend Biotech is the largest standalone cell therapy company and a pioneer in treatments that change cancer care forever. The company is at the forefront of the CAR-T cell therapy revolution with CARVYKTI®, a one-time treatment for relapsed or refractory multiple myeloma, which it develops and markets with collaborator Johnson & Johnson. Centered in the US, Legend is building an end-to-end cell therapy company by expanding its leadership to maximize CARVYKTI’s patient access and therapeutic potential. From this platform, the company plans to drive future innovation across its pipeline of cutting-edge cell therapy modalities.
Learn more at www.legendbiotech.com and follow us on X (formerly Twitter) and LinkedIn.
INVESTOR CONTACT:
Caroline Paul
Tel: (973) 650-5832
caroline.paul@legendbiotech.com
PRESS CONTACT:
Mary Ann Ondish
Tel: (914) 552-4625
media@legendbiotech.com
FAQ
When will Legend Biotech (LEGN) release its Q4 and full-year 2024 financial results?
How can investors access Legend Biotech's (LEGN) Q4 2024 earnings call?
What will be discussed during Legend Biotech's (LEGN) upcoming earnings call on March 11, 2025?
Where can investors find Legend Biotech's (LEGN) Q4 2024 earnings release after the conference call?
